Sfoglia per Autore
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS
2008 Guarneri, V.; Giovannelli, S.; Ficarra, G.; Bettelli, S.; Piacentini, F.; Barbieri, E.; Dieci, Mv.; Jovic, G.; Conte, Pf.
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management
2008 Guarneri, Valentina; Giovannelli, Simona; Ficarra, G; Bettelli, Stefania Raffaella; Maiorana, Antonino; Piacentini, Federico; Barbieri, Elena; Dieci, Maria Vittoria; D'Amico, Roberto; Jovic, Gordana; Conte, Pierfranco
KI67 AS A PREDICTOR OF RESPONSE AND LONG TERM SURVIVAL IN HORMONE RECEPTOR POSITIVE/HER2 NEGATIVE BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY
2010 Barbieri, Elena; Piacentini, Federico; Dieci, Maria Vittoria; Ficarra, Guido; Conte, Pierfranco; Guarneri, Valentina
Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer
2010 Guarneri, Valentina; Barbieri, Elena; Dieci, Mv; Piacentini, Federico; Conte, Pierfranco
Ki67 as a Predictor of Response and Long Term Survival in Hormone Receptor Positive/HER2 Negative Breast Cancer Patients Treated with Preoperative Chemotherapy
2010 Barbieri, Elena; Piacentini, Federico; Dieci, Maria Vittoria; Ficarra, G; Conte, Pierfranco; Guarneri, Valentina
Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts
2011 Barbieri, Elena; Piacentini, Federico; Dieci, Maria Vittoria; Ficarra, G; Bettelli, Stefania Raffaella; Conte, Pierfranco; Guarneri, Valentina
Timing for starting second line therapy in recurrent ovarian cancer.
2011 Guarneri, Valentina; Barbieri, Elena; Dieci, Maria Vittoria; Piacentini, Federico; Conte, Pierfranco
Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II-III Breast Cancer
2011 Guarneri, Valentina; Pecchi, A; Piacentini, Federico; Barbieri, Elena; Dieci, Mv; Ficarra, G; Tazzioli, Giovanni; Frassoldati, A; Battista, R; Canossi, Barbara; Mauri, C; D'Amico, Roberto; Conte, Pierfranco; Torricelli, Pietro
Tumori ginecologici
2012 Conte, Pierfranco; Barbieri, Elena; Guarneri, Valentina; Piacentini, Federico; Dieci, Maria Vittoria
MANAGEMENT OF ADVANCED BREAST CANCER: HOW TO INTEGRATE SCIENTIFIC DATA AND CLINICAL JUDGMENT
2012 Conte, P.; Dieci, M. V.; Piacentini, F.
Prognostic role of HER2 loss after neoadjuvant therapy in patients with HER2-positive operable breast cancer
2012 Guarneri, Valentina; Barbieri, Elena; Piacentini, Federico; Dieci, Maria Vittoria; Omarini, Claudia; G., Ficarra; Bettelli, Stefania Raffaella; Conte, Pierfranco
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis.
2012 Dieci, Maria Vittoria; Barbieri, Elena; Bettelli, Stefania Raffaella; Piacentini, Federico; Omarini, Claudia; Ficarra, G; Balduzzi, Sara; Dominici, Massimo; Conte, Pierfranco; Guarneri, Valentina
Preoperative carboplatin-paclitaxel-bevacizumab in triple negative breast cancer: Final results of the phase II CA.Pa.Be study
2013 Guarneri, Valentina; Boni, C; Puglisi, F; Cagossi, K; Piacentini, Federico; Bisagni, G; Dieci, Maria Vittoria; Barbieri, E; Vicini, Roberto; Conte, P.
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis
2013 Dieci, Maria Vittoria; Barbieri, Elena; Piacentini, Federico; Ficarra, G; Bettelli, Stefania Raffaella; Dominici, Massimo; Conte, Pierfranco; Guarneri, Valentina
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients
2013 Guarneri, Valentina; Dieci, Maria Vittoria; Barbieri, E; Piacentini, Federico; Omarini, Claudia; Ficarra, G; Bettelli, Stefania Raffaella; Conte, Pierfranco
Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence
2013 Dieci, Maria Vittoria; Barbieri, Elena; Aicha, Goubar; Andre, Fabrice; Omarini, Claudia; Bettelli, Stefania Raffaella; Piacentini, Federico; Guido, Ficarra; Pier, Franco Conte; Guarneri, Valentina
Quantitative expression of estrogen receptor on relapse biopsy for ER-positive breast cancer: prognostic impact
2014 Dieci, Maria Vittoria; Piacentini, Federico; Dominici, Massimo; Omarini, Claudia; Goubar, Aicha; Ficarra, Guido; Conte, Pierfranco; Guarneri, Valentina
Rare breast cancer subtypes: Histological, molecular, and clinical peculiarities
2014 Dieci, Maria Vittoria; Orvieto, Enrico; Dominici, Massimo; Conte, Pierfranco; Guarneri, Valentina
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer
2016 Musolino, A; Naldi, N; Dieci, Maria Vittoria; Zanoni, Daniele; Rimanti, Anita; Boggiani, D; Sgargi, P; Generali, Dg; Piacentini, Federico; Ambroggi, M; Cagossi, K; Gianni, L; Sarti, S; Bisagni, G; Ardizzoni, Andrea; Conte, Pf; Guarneri, Valentina
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials (Breast Cancer Research and Treatment, (2017), 163, 2, (295-302), 10.1007/s10549-017-4191-y)
2017 Dieci, M. V.; Frassoldati, A.; Generali, D.; Bisagni, G.; Piacentini, F.; Cavanna, L.; Cagossi, K.; Puglisi, F.; Michelotti, A.; Berardi, R.; Banna, G.; Goubar, A.; Ficarra, G.; Griguolo, G.; Conte, P.; Guarneri, V.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS | 1-gen-2008 | Guarneri, V.; Giovannelli, S.; Ficarra, G.; Bettelli, S.; Piacentini, F.; Barbieri, E.; Dieci, Mv.; Jovic, G.; Conte, Pf. | |
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management | 1-gen-2008 | Guarneri, Valentina; Giovannelli, Simona; Ficarra, G; Bettelli, Stefania Raffaella; Maiorana, Antonino; Piacentini, Federico; Barbieri, Elena; Dieci, Maria Vittoria; D'Amico, Roberto; Jovic, Gordana; Conte, Pierfranco | |
KI67 AS A PREDICTOR OF RESPONSE AND LONG TERM SURVIVAL IN HORMONE RECEPTOR POSITIVE/HER2 NEGATIVE BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY | 1-gen-2010 | Barbieri, Elena; Piacentini, Federico; Dieci, Maria Vittoria; Ficarra, Guido; Conte, Pierfranco; Guarneri, Valentina | |
Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer | 1-gen-2010 | Guarneri, Valentina; Barbieri, Elena; Dieci, Mv; Piacentini, Federico; Conte, Pierfranco | |
Ki67 as a Predictor of Response and Long Term Survival in Hormone Receptor Positive/HER2 Negative Breast Cancer Patients Treated with Preoperative Chemotherapy | 1-gen-2010 | Barbieri, Elena; Piacentini, Federico; Dieci, Maria Vittoria; Ficarra, G; Conte, Pierfranco; Guarneri, Valentina | |
Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts | 1-gen-2011 | Barbieri, Elena; Piacentini, Federico; Dieci, Maria Vittoria; Ficarra, G; Bettelli, Stefania Raffaella; Conte, Pierfranco; Guarneri, Valentina | |
Timing for starting second line therapy in recurrent ovarian cancer. | 1-gen-2011 | Guarneri, Valentina; Barbieri, Elena; Dieci, Maria Vittoria; Piacentini, Federico; Conte, Pierfranco | |
Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II-III Breast Cancer | 1-gen-2011 | Guarneri, Valentina; Pecchi, A; Piacentini, Federico; Barbieri, Elena; Dieci, Mv; Ficarra, G; Tazzioli, Giovanni; Frassoldati, A; Battista, R; Canossi, Barbara; Mauri, C; D'Amico, Roberto; Conte, Pierfranco; Torricelli, Pietro | |
Tumori ginecologici | 1-gen-2012 | Conte, Pierfranco; Barbieri, Elena; Guarneri, Valentina; Piacentini, Federico; Dieci, Maria Vittoria | |
MANAGEMENT OF ADVANCED BREAST CANCER: HOW TO INTEGRATE SCIENTIFIC DATA AND CLINICAL JUDGMENT | 1-gen-2012 | Conte, P.; Dieci, M. V.; Piacentini, F. | |
Prognostic role of HER2 loss after neoadjuvant therapy in patients with HER2-positive operable breast cancer | 1-gen-2012 | Guarneri, Valentina; Barbieri, Elena; Piacentini, Federico; Dieci, Maria Vittoria; Omarini, Claudia; G., Ficarra; Bettelli, Stefania Raffaella; Conte, Pierfranco | |
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. | 1-gen-2012 | Dieci, Maria Vittoria; Barbieri, Elena; Bettelli, Stefania Raffaella; Piacentini, Federico; Omarini, Claudia; Ficarra, G; Balduzzi, Sara; Dominici, Massimo; Conte, Pierfranco; Guarneri, Valentina | |
Preoperative carboplatin-paclitaxel-bevacizumab in triple negative breast cancer: Final results of the phase II CA.Pa.Be study | 1-gen-2013 | Guarneri, Valentina; Boni, C; Puglisi, F; Cagossi, K; Piacentini, Federico; Bisagni, G; Dieci, Maria Vittoria; Barbieri, E; Vicini, Roberto; Conte, P. | |
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis | 1-gen-2013 | Dieci, Maria Vittoria; Barbieri, Elena; Piacentini, Federico; Ficarra, G; Bettelli, Stefania Raffaella; Dominici, Massimo; Conte, Pierfranco; Guarneri, Valentina | |
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients | 1-gen-2013 | Guarneri, Valentina; Dieci, Maria Vittoria; Barbieri, E; Piacentini, Federico; Omarini, Claudia; Ficarra, G; Bettelli, Stefania Raffaella; Conte, Pierfranco | |
Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence | 1-gen-2013 | Dieci, Maria Vittoria; Barbieri, Elena; Aicha, Goubar; Andre, Fabrice; Omarini, Claudia; Bettelli, Stefania Raffaella; Piacentini, Federico; Guido, Ficarra; Pier, Franco Conte; Guarneri, Valentina | |
Quantitative expression of estrogen receptor on relapse biopsy for ER-positive breast cancer: prognostic impact | 1-gen-2014 | Dieci, Maria Vittoria; Piacentini, Federico; Dominici, Massimo; Omarini, Claudia; Goubar, Aicha; Ficarra, Guido; Conte, Pierfranco; Guarneri, Valentina | |
Rare breast cancer subtypes: Histological, molecular, and clinical peculiarities | 1-gen-2014 | Dieci, Maria Vittoria; Orvieto, Enrico; Dominici, Massimo; Conte, Pierfranco; Guarneri, Valentina | |
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer | 1-gen-2016 | Musolino, A; Naldi, N; Dieci, Maria Vittoria; Zanoni, Daniele; Rimanti, Anita; Boggiani, D; Sgargi, P; Generali, Dg; Piacentini, Federico; Ambroggi, M; Cagossi, K; Gianni, L; Sarti, S; Bisagni, G; Ardizzoni, Andrea; Conte, Pf; Guarneri, Valentina | |
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials (Breast Cancer Research and Treatment, (2017), 163, 2, (295-302), 10.1007/s10549-017-4191-y) | 1-gen-2017 | Dieci, M. V.; Frassoldati, A.; Generali, D.; Bisagni, G.; Piacentini, F.; Cavanna, L.; Cagossi, K.; Puglisi, F.; Michelotti, A.; Berardi, R.; Banna, G.; Goubar, A.; Ficarra, G.; Griguolo, G.; Conte, P.; Guarneri, V. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile